Study Stopped
Budgetary issues
Optimal Management of Pain in Hospitalized Patients - Opioid Tolerant Populations.
Pain Management Options for Opioid Tolerant Patients: a Randomized Controlled Trial
1 other identifier
interventional
60
1 country
2
Brief Summary
Pain is a symptom that drives hospital admissions, and pain management is required by most patients during their hospital stay. Further, the use of medications such as opioids can lead to upward-spiraling doses, especially among chronic pain patients whose resource utilization rates are high. Many initiatives aim to reduce the costs of these "high-resource utilizing" patients. One exciting aspect of improving the management of pain is that this may help prevent patients from ever becoming high-cost in the first place. The purpose of this study is to examine the impacts of an early and sustained intervention pathway, in comparison to the current standard of care, for the treatment of pain in opioid tolerant patients. It is hypothesized that patients randomized to the intervention pathway, in comparison to the control, will lead to decreased costs of care, a reduction in opioid usage within 3 and 6 months, and decrease in hospital readmission rates.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable pain
Started Jan 2016
Longer than P75 for not_applicable pain
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2015
CompletedFirst Posted
Study publicly available on registry
June 12, 2015
CompletedStudy Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 29, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2019
CompletedFebruary 11, 2025
February 1, 2025
3.6 years
January 13, 2015
February 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Returns to Acute Care
Hospital Readmissions and Emergency Department Utilizations
Discharge through 90 days post-discharge
Secondary Outcomes (9)
Opioid Analgesic Use
Discharge through 90 days post-discharge
Opioid Analgesic Use
Admission through 12 months post-discharge
Opioid Tolerance Status
Admission through 12 months post-discharge
Pain at Discharge
Measured upon day of discharge from index hospitalization; up to 18 months from the date of randomization
Hospital Length of Stay
Measured upon day of discharge from index hospitalization; up to 18 months from the date of randomization
- +4 more secondary outcomes
Study Arms (2)
Control Group
NO INTERVENTIONThose randomized into the control group will receive the current standard of care for pain management. This standard care pathway involves a pain management specialist consultation only at the request of the primary admitting team. The pain management consultation can occur at any time during the patient's inpatient stay and care by these specialists ends at discharge.
Treatment Group
EXPERIMENTALSubjects randomized into the treatment (early intervention) group will receive the New Clinical Pathway: pain management care coordinated by pain-management specialists from inpatient admission through 60 days after discharge.
Interventions
Eligibility Criteria
You may qualify if:
- Adult patients (18 years and older)
- Known opioid tolerant (as determined per FDA criteria)
- Agree to sign the informed consent and HIPAA forms
You may not qualify if:
- Patients under the age of 18 years
- No known opioid tolerance
- Do not agree to sign the informed consent and HIPAA forms
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- Massachusetts Institute of Technologycollaborator
- University of California, Irvinecollaborator
Study Sites (2)
University of California, Irvine Medical Center
Orange, California, 92868, United States
Duke University Medical Center
Durham, North Carolina, 27710, United States
Related Publications (19)
Raebel MA, Newcomer SR, Reifler LM, Boudreau D, Elliott TE, DeBar L, Ahmed A, Pawloski PA, Fisher D, Donahoo WT, Bayliss EA. Chronic use of opioid medications before and after bariatric surgery. JAMA. 2013 Oct 2;310(13):1369-76. doi: 10.1001/jama.2013.278344.
PMID: 24084922BACKGROUNDBrown EG, Burgess D, Li CS, Canter RJ, Bold RJ. Hospital readmissions: necessary evil or preventable target for quality improvement. Ann Surg. 2014 Oct;260(4):583-9; discussion 589-91. doi: 10.1097/SLA.0000000000000923.
PMID: 25203874BACKGROUNDGulur P, Williams L, Chaudhary S, Koury K, Jaff M. Opioid tolerance--a predictor of increased length of stay and higher readmission rates. Pain Physician. 2014 Jul-Aug;17(4):E503-7.
PMID: 25054400BACKGROUNDKessler ER, Shah M, Gruschkus SK, Raju A. Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes. Pharmacotherapy. 2013 Apr;33(4):383-91. doi: 10.1002/phar.1223.
PMID: 23553809BACKGROUNDLembke A. Why doctors prescribe opioids to known opioid abusers. How cultural attitudes and financial disincentives affect the prescribing habits of physicians. Minn Med. 2013 Mar;96(3):36-7. No abstract available.
PMID: 23930467BACKGROUNDVolkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies--tackling the opioid-overdose epidemic. N Engl J Med. 2014 May 29;370(22):2063-6. doi: 10.1056/NEJMp1402780. Epub 2014 Apr 23. No abstract available.
PMID: 24758595BACKGROUNDPugely AJ, Martin CT, Gao Y, Mendoza-Lattes S. Causes and risk factors for 30-day unplanned readmissions after lumbar spine surgery. Spine (Phila Pa 1976). 2014 Apr 20;39(9):761-8. doi: 10.1097/BRS.0000000000000270.
PMID: 24525993BACKGROUNDHazratjee N, Agito M, Lopez R, Lashner B, Rizk MK. Hospital readmissions in patients with inflammatory bowel disease. Am J Gastroenterol. 2013 Jul;108(7):1024-32. doi: 10.1038/ajg.2012.343.
PMID: 23820989BACKGROUNDCenters for Disease Control and Prevention (CDC). CDC grand rounds: prescription drug overdoses - a U.S. epidemic. MMWR Morb Mortal Wkly Rep. 2012 Jan 13;61(1):10-3.
PMID: 22237030BACKGROUNDBell JR. Australian trends in opioid prescribing for chronic non-cancer pain, 1986-1996. Med J Aust. 1997 Jul 7;167(1):26-9. doi: 10.5694/j.1326-5377.1997.tb138759.x.
PMID: 9236756BACKGROUNDBot AG, Bekkers S, Arnstein PM, Smith RM, Ring D. Opioid use after fracture surgery correlates with pain intensity and satisfaction with pain relief. Clin Orthop Relat Res. 2014 Aug;472(8):2542-9. doi: 10.1007/s11999-014-3660-4. Epub 2014 Apr 29.
PMID: 24777731BACKGROUNDHerzig SJ, Rothberg MB, Cheung M, Ngo LH, Marcantonio ER. Opioid utilization and opioid-related adverse events in nonsurgical patients in US hospitals. J Hosp Med. 2014 Feb;9(2):73-81. doi: 10.1002/jhm.2102. Epub 2013 Nov 13.
PMID: 24227700BACKGROUNDApfelbaum JL, Chen C, Mehta SS, Gan TJ. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg. 2003 Aug;97(2):534-540. doi: 10.1213/01.ANE.0000068822.10113.9E.
PMID: 12873949BACKGROUNDTorrance N, Elliott AM, Lee AJ, Smith BH. Severe chronic pain is associated with increased 10 year mortality. A cohort record linkage study. Eur J Pain. 2010 Apr;14(4):380-6. doi: 10.1016/j.ejpain.2009.07.006. Epub 2009 Sep 1.
PMID: 19726210BACKGROUNDPavon JM, Zhao Y, McConnell E, Hastings SN. Identifying risk of readmission in hospitalized elderly adults through inpatient medication exposure. J Am Geriatr Soc. 2014 Jun;62(6):1116-21. doi: 10.1111/jgs.12829. Epub 2014 May 6.
PMID: 24802165BACKGROUNDMuthuvel G, Tevis SE, Liepert AE, Agarwal SK, Kennedy GD. A composite index for predicting readmission following emergency general surgery. J Trauma Acute Care Surg. 2014 Jun;76(6):1467-72. doi: 10.1097/TA.0000000000000223.
PMID: 24854317BACKGROUNDWilson GC, Cutler Quillin R 3rd, Sutton JM, Wima K, Shaw JJ, Hoehn RS, Paquette IM, Abbott DE, Shah SA. Factors related to readmission after major elective surgery. Dig Dis Sci. 2015 Jan;60(1):47-53. doi: 10.1007/s10620-014-3306-0. Epub 2014 Jul 27.
PMID: 25064214BACKGROUNDAnderegg SV, Wilkinson ST, Couldry RJ, Grauer DW, Howser E. Effects of a hospitalwide pharmacy practice model change on readmission and return to emergency department rates. Am J Health Syst Pharm. 2014 Sep 1;71(17):1469-79. doi: 10.2146/ajhp130686.
PMID: 25147171BACKGROUNDTayne S, Merrill CA, Shah SN, Kim J, Mackey WC. Risk factors for 30-day readmissions and modifying postoperative care after gastric bypass surgery. J Am Coll Surg. 2014 Sep;219(3):489-95. doi: 10.1016/j.jamcollsurg.2014.03.054. Epub 2014 May 20.
PMID: 25151343BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Padma Gulur, MD
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 13, 2015
First Posted
June 12, 2015
Study Start
January 1, 2016
Primary Completion
July 29, 2019
Study Completion
July 31, 2019
Last Updated
February 11, 2025
Record last verified: 2025-02